Johnson & Johnson (JNJ) reported its Q2 2026 results on July 15, 2026, before market open. The company reported an EPS of 2.90 USD, beating the analyst estimate of 2.85 USD by 1.6%. Revenue reached 25310 million USD for the quarter. Following the release, the stock price decreased by 2.69%.
Generated automatically from our data — as of July 23, 2026
Key figures at a glance
Estimate (EPS): 2.85 USD
Reported (EPS): 2.90 USD
Price reaction: -2.7%
Frequently asked questions
Did Johnson & Johnson beat or miss earnings-per-share expectations?
Johnson & Johnson beat the analyst estimate of 2.85 USD earnings per share (Q2 2026) by 1.6%, reporting 2.90 USD.
How did Johnson & Johnson stock react to the earnings report?
Johnson & Johnson stock fell 2.7% on the trading day following the release.
What was Johnson & Johnson's revenue in Q2 2026?
Johnson & Johnson reported revenue of 25,310M USD in Q2 2026.